E
Erick Mora-Ramirez
Researcher at University of Costa Rica
Publications - 7
Citations - 139
Erick Mora-Ramirez is an academic researcher from University of Costa Rica. The author has contributed to research in topics: Radionuclide therapy & Dosimetry. The author has an hindex of 5, co-authored 6 publications receiving 63 citations. Previous affiliations of Erick Mora-Ramirez include University of Toulouse & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
OpenDose: Open-Access Resource for Nuclear Medicine Dosimetry.
Maxime Chauvin,Damian Borys,Francesca Botta,Pawel Bzowski,Jérémie Dabin,Ana M. Denis-Bacelar,A. Desbrée,Nadia Falzone,B.Q. Lee,Andrea Mairani,Alessandra Malaroda,Gilles Mathieu,Erin McKay,Erick Mora-Ramirez,Erick Mora-Ramirez,A P Robinson,A P Robinson,David Sarrut,Lara Struelens,Alex Vergara Gil,Manuel Bardiès +20 more
TL;DR: The OpenDose collaboration produced SAFs for all source region and target combinations of the 2 International Commission on Radiological Protection Publication 110 adult reference models in good agreement at all energies, with SDs below individual statistical uncertainties.
Journal ArticleDOI
Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate.
Lore Santoro,Erick Mora-Ramirez,Erick Mora-Ramirez,Dorian Trauchessec,Soufiane Chouaf,Pierre Eustache,Jean-Pierre Pouget,Pierre-Olivier Kotzki,Manuel Bardiès,Emmanuel Deshayes +9 more
TL;DR: This study shows the technical feasibility of patient dosimetry in clinical practice and the need to obtain patient-specific information during PRRT with 177Lu-DOTATATE and the obtained AD/A admin values were in agreement with the literature data.
Journal ArticleDOI
Comparison of commercial dosimetric software platforms in patients treated with 177 Lu-DOTATATE for peptide receptor radionuclide therapy.
Erick Mora-Ramirez,Erick Mora-Ramirez,Lore Santoro,Emmanuelle Cassol,Juan C. Ocampo‐Ramos,Naomi Clayton,Gunjan Kayal,Soufiane Chouaf,Dorian Trauchessec,Jean-Pierre Pouget,Pierre-Olivier Kotzki,Emmanuel Deshayes,Manuel Bardiès +12 more
TL;DR: Five commercial dosimetric software platforms are compared based on the analysis of clinical datasets of patients who benefited from peptide receptor radionuclide therapy (PRRT) with 177Lu‐DOTATATE (LUTATHERA®) to quantitatively compare the performances of currently available platforms.
Journal ArticleDOI
Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats.
A.S. Salabert,Erick Mora-Ramirez,Erick Mora-Ramirez,Erick Mora-Ramirez,M. Beaurain,Mathieu Alonso,Charlotte Fontan,Hafid Belhadj Tahar,Marie Laure Boizeau,Mathieu Tafani,Manuel Bardiès,Manuel Bardiès,Pierre Payoux +12 more
TL;DR: The presented compound exhibits stability in plasma and plasma protein binding very similar to memantine, and its dosimetry shows that it is suitable for use in humans due to a low total effective dose compared to other PET radiotracers.
Journal ArticleDOI
Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0
Lore Santoro,Laurine Pitalot,Dorian Trauchessec,Erick Mora-Ramirez,Erick Mora-Ramirez,P.O. Kotzki,Manuel Bardiès,Emmanuel Deshayes +7 more
TL;DR: The results validate the use of PLANET®Dose in clinical routine for patient dosimetry after targeted radiotherapy with [177Lu]Lu-DOTA-TATE and concordant with those calculated with the currently used software and in agreement with the literature.